Skip to content

Public FDA record

Z-0694-2018: Footswitch accessory to the CUSA Clarity Ultrasonic Tissue Ablation System; Catalogue No: C7000 Product

Recall record Z-0694-2018 for Integra LifeSciences Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0694-2018
Company in FDA record
Integra LifeSciences Corp.
FDA record creation date
Feb 23, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A faulty footswitch may result in unintended ultrasonic fragmentation activation. There are two scenarios when the failure mode may occur: 1) Ultrasonic fragmentation may be inadvertently activated at start-up or at the initial use once the footswitch is connected to the console and after the user primes the system, performs a handpiece test, and enters the Main Screen. 2) Ultrasonic fragmentation may remain activated during surgical use once the foot pedal is disengaged slowly.

Source facts

Action
Integra I sent an Urgent Voluntary Medical Device Removal Field Safety Notice letter dated September 26, 2017 to their customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to check the footswitch you received with your purchase of the CUSA Clarity Console, Catalog # C7000for the lot number on the back of the footswitch. Reference pictures are provided on the next page. Compare it to the affected footswitch lot numbers on the next page. If you do have an affected lot number, replace this footswitch with the one that has been provided to you by your sales representative. If you have not yet been provided with the replacement footswitch, please contact your sales representative as soon as possible for a replacement footswitch. 2.Complete the information on the form and either provide it to your sales representative or email or fax as indicated on the form. Keep a copy of the form for your records. For questions regarding the instructions contact SSS E&L at sssel@integralife.com or 888-419-0625 option 2.
Initiated
2017-09-26
Root cause
Process control
Terminated
2018-08-14
Distribution
Worldwide Distribution - US Nationwide in 33 states: AL, AR, CA, CO, CT, FL, GA, IA, ID, IL, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NM, NY, OH, OK, OR, PA, TN, TX, VA, WA, WI in the countries of Greece, South Africa, France, Germany, Italy, United Kingdom, Sweden, Netherlands, and Dominican Republic.
Recall number
Z-0694-2018
Recall status
Terminated
CDRH record ID
161507
FDA record created
2018-02-23
Recall event number
79171

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗